• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在K562人红白血病细胞中鉴定出一种高度糖基化的甲氨蝶呤膜载体,该细胞中四氢叶酸辅因子和甲氨蝶呤转运上调。

Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport.

作者信息

Matherly L H, Czajkowski C A, Angeles S M

机构信息

Developmental Therapeutics Program, Michigan Cancer Foundation, Detroit 48201.

出版信息

Cancer Res. 1991 Jul 1;51(13):3420-6.

PMID:2054782
Abstract

A K562 human erythroleukemia line (designated K562.4CF) was selected for increased tetrahydrofolate cofactor transport in a growth-limiting concentration (0.4 nM) of (6R,S)-5-formyltetrahydrofolate. K562.4CF cells exhibited elevated methotrexate uptake relative to parental cells, attributable to a 10-fold increased influx Vmax. The rate of methotrexate efflux in K562.4CF cells was somewhat increased (55%) as well. The transport system in K562.4CF cells had similar and high apparent binding affinities for methotrexate and 5-formyltetrahydrofolate and a markedly reduced affinity for folic acid, properties typically associated with the "classical" methotrexate/tetrahydrofolate cofactor transporter in tumor cells. Methotrexate uptake in K562.4CF cells decreased substantially under nonselective conditions; high levels of transport were restored in 0.4 nM 5-formyltetrahydrofolate. Treatment of parental and K562.4CF cells with N-hydroxysuccinimide methotrexate inhibited methotrexate influx. N-Hydroxysuccinimide-[3H]methotrexate (700 nM) radiolabeled a broadly migrating band at Mr 76,000-85,000. Incorporation from N-hydroxysuccinimide-[3H]methotrexate into this band was increased 7-fold in K562.4CF over parental cells and was blocked by unlabeled methotrexate, (6S)-5-formyltetrahydrofolate, or, to a lesser extent, folic acid. Whereas incubation with endoglycosidase F had no effect on the electrophoretic migration of the labeled protein, treatment with endoglycosidase F and glycopeptidase F, or endo-beta-galactosidase, reduced the apparent molecular weight to Mr approximately 52,000 or approximately 58,000, respectively. These results suggest that the high-affinity transporter in K562.4CF cells is an N-linked glycoprotein containing internal beta-galactosidic linkages in, or immediately after, unbranched poly-N-acetyllactosamine sequences. Differences in the level of glycosylation may, in part, account for the disparity in the apparent sizes of the homologous folate transport proteins from human and murine cells.

摘要

选择一株K562人红白血病细胞系(命名为K562.4CF),使其在生长限制浓度(0.4 nM)的(6R,S)-5-甲酰四氢叶酸中四氢叶酸辅因子转运增加。与亲代细胞相比,K562.4CF细胞的甲氨蝶呤摄取量升高,这归因于流入Vmax增加了10倍。K562.4CF细胞中甲氨蝶呤的外排速率也有所增加(55%)。K562.4CF细胞中的转运系统对甲氨蝶呤和5-甲酰四氢叶酸具有相似且较高的表观结合亲和力,而对叶酸的亲和力明显降低,这些特性通常与肿瘤细胞中的“经典”甲氨蝶呤/四氢叶酸辅因子转运体相关。在非选择性条件下,K562.4CF细胞中甲氨蝶呤的摄取量大幅下降;在0.4 nM 5-甲酰四氢叶酸中可恢复高水平的转运。用N-羟基琥珀酰亚胺甲氨蝶呤处理亲代细胞和K562.4CF细胞可抑制甲氨蝶呤的流入。N-羟基琥珀酰亚胺-[3H]甲氨蝶呤(700 nM)标记了一条迁移范围较宽的条带,其分子量为76,000 - 85,000。与亲代细胞相比,K562.4CF细胞中从N-羟基琥珀酰亚胺-[3H]甲氨蝶呤掺入该条带的量增加了7倍,并且被未标记的甲氨蝶呤、(6S)-5-甲酰四氢叶酸或程度较轻的叶酸所阻断。虽然用内切糖苷酶F孵育对标记蛋白的电泳迁移没有影响,但用内切糖苷酶F和糖肽酶F或内切β-半乳糖苷酶处理后,表观分子量分别降至约52,000或约58,000。这些结果表明,K562.4CF细胞中的高亲和力转运体是一种N-连接糖蛋白,在未分支的多聚N-乙酰乳糖胺序列中或之后含有内部β-半乳糖苷键。糖基化水平的差异可能部分解释了人和鼠细胞中同源叶酸转运蛋白表观大小的差异。

相似文献

1
Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells up-regulated for tetrahydrofolate cofactor and methotrexate transport.在K562人红白血病细胞中鉴定出一种高度糖基化的甲氨蝶呤膜载体,该细胞中四氢叶酸辅因子和甲氨蝶呤转运上调。
Cancer Res. 1991 Jul 1;51(13):3420-6.
2
Characterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors.利用针对甲氨蝶呤和四氢叶酸辅因子膜载体的抗体对人肿瘤细胞中转运介导的甲氨蝶呤耐药性进行表征。
J Biol Chem. 1992 Nov 15;267(32):23253-60.
3
Identification of a membrane-associated folate-binding protein in human leukemic CCRF-CEM cells with transport-related methotrexate resistance.在具有与转运相关的甲氨蝶呤抗性的人白血病CCRF-CEM细胞中鉴定一种膜相关叶酸结合蛋白。
Cancer Res. 1989 May 1;49(9):2455-9.
4
Functional activity of the reduced folate carrier in KB, MA104, and IGROV-I cells expressing folate-binding protein.表达叶酸结合蛋白的KB、MA104和IGROV-I细胞中还原型叶酸载体的功能活性。
Cancer Res. 1995 Sep 1;55(17):3795-802.
5
Expression of a folate binding protein in L1210 cells grown in low folate medium.在低叶酸培养基中生长的L1210细胞中叶酸结合蛋白的表达。
Cancer Res. 1989 Apr 15;49(8):1959-63.
6
Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.白血病小鼠甲氨蝶呤治疗期间L1210细胞内叶酸类似物转运增强:作用性质、可能的宿主介导及药代动力学意义的证据
Cancer Res. 1987 Oct 15;47(20):5334-9.
7
Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.新型胸苷酸合成酶苯并喹唑啉抑制剂1843U89的生化与细胞药理学
Cancer Res. 1993 Feb 15;53(4):810-8.
8
The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.多靶点抗叶酸剂(MTA)的转运机制及其在甲氨蝶呤转运明显受损的细胞中的交叉耐药模式。
Clin Cancer Res. 2000 Sep;6(9):3687-95.
9
Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.对HeLa细胞中一种叶酸转运体的特性进行表征,该转运体对培美曲塞具有低pH最佳值和高亲和力,与还原型叶酸载体不同。
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6256-64. doi: 10.1158/1078-0432.CCR-04-0645.
10
Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier. Selective effect on carrier-mediated transport of physiological concentrations of reduced folates.甲氨蝶呤在还原型叶酸载体水平升高的变异型人CCRF - CEM白血病细胞中的转运。对生理浓度还原型叶酸的载体介导转运的选择性作用。
J Biol Chem. 1990 Oct 25;265(30):18272-7.

引用本文的文献

1
Reduced folate carrier 1 is present in retinal microvessels and crucial for the inner blood retinal barrier integrity.还原叶酸载体 1 存在于视网膜微血管中,对于维持内血液视网膜屏障的完整性至关重要。
Fluids Barriers CNS. 2023 Jun 16;20(1):47. doi: 10.1186/s12987-023-00442-3.
2
Overview of Methotrexate Toxicity: A Comprehensive Literature Review.甲氨蝶呤毒性概述:一项全面的文献综述
Cureus. 2022 Sep 23;14(9):e29518. doi: 10.7759/cureus.29518. eCollection 2022 Sep.
3
Identification of the Receptor Used by the Ecotropic Mouse GLN Endogenous Retrovirus.
鉴定嗜同性鼠内源性反转录病毒使用的受体。
J Virol. 2019 Feb 19;93(5). doi: 10.1128/JVI.01125-18. Print 2019 Mar 1.
4
Functional and mechanistic roles of the human proton-coupled folate transporter transmembrane domain 6-7 linker.人类质子偶联叶酸转运体跨膜结构域6-7连接区的功能及作用机制
Biochem J. 2016 Oct 15;473(20):3545-3562. doi: 10.1042/BCJ20160399. Epub 2016 Aug 11.
5
Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.叶酸缺乏和谷氨酸增加在接受甲氨蝶呤治疗的青少年特发性关节炎患者中。
Arthritis Rheumatol. 2014 Dec;66(12):3476-85. doi: 10.1002/art.38865.
6
Post-transcriptional regulation of the human reduced folate carrier as a novel adaptive mechanism in response to folate excess or deficiency.人还原型叶酸载体的转录后调控作为一种应对叶酸过量或缺乏的新型适应性机制。
Biosci Rep. 2014 Aug 6;34(4):e00130. doi: 10.1042/BSR20140065.
7
Biology of the major facilitative folate transporters SLC19A1 and SLC46A1.主要易化型叶酸转运蛋白SLC19A1和SLC46A1的生物学特性
Curr Top Membr. 2014;73:175-204. doi: 10.1016/B978-0-12-800223-0.00004-9.
8
The major facilitative folate transporters solute carrier 19A1 and solute carrier 46A1: biology and role in antifolate chemotherapy of cancer.主要促进叶酸转运蛋白溶质载体 19A1 和溶质载体 46A1:生物学及在癌症抗叶酸化疗中的作用。
Drug Metab Dispos. 2014 Apr;42(4):632-49. doi: 10.1124/dmd.113.055723. Epub 2014 Jan 6.
9
Low-dose methotrexate results in the selective accumulation of aminoimidazole carboxamide ribotide in an erythroblastoid cell line.低剂量甲氨蝶呤导致红细胞样细胞系中氨甲酰咪唑核苷酸的选择性积累。
J Pharmacol Exp Ther. 2013 Oct;347(1):154-63. doi: 10.1124/jpet.113.206672. Epub 2013 Jul 25.
10
Functional loss of the reduced folate carrier enhances the antitumor activities of novel antifolates with selective uptake by the proton-coupled folate transporter.还原叶酸载体功能丧失增强了新型抗叶酸药物的抗肿瘤活性,这些药物通过质子偶联叶酸转运体选择性摄取。
Mol Pharmacol. 2012 Oct;82(4):591-600. doi: 10.1124/mol.112.079004. Epub 2012 Jun 26.